Trial Profile
Peri-neural Dexmedetomidine as an Adjuvant to Bupivacaine-induced Paravertebral Block in Patients Undergoing Thoracotomy
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 12 Feb 2016
Price :
$35
*
At a glance
- Drugs Dexmedetomidine (Primary) ; Bupivacaine
- Indications Postoperative pain
- Focus Therapeutic Use
- 01 Feb 2016 Status changed from recruiting to completed, according to ClinicalTrials.gov record.
- 31 Mar 2015 New trial record